Author name: Julie Tits

Network

REGULATED INFORMATION – Back to the connectivity roots of Option

Leuven, Belgium – 21 January 2026 – 7:30 AM CET, Option NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) Looking back on Crescent NV’s results in 2025, below are some notes regarding a number of achievements realised during the second half of 2025, i.e. after Remoticom BV’s partial exit. – Immediate recovery of operating results […]

REGULATED INFORMATION – Back to the connectivity roots of Option Read More »

Leuven, Belgium – 21 January 2026 – 7:30 AM CET, Option NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) Looking back on Crescent NV’s results in 2025, below are some notes regarding a number of achievements realised during the second half of 2025, i.e. after Remoticom BV’s partial exit. – Immediate recovery of operating results

REGULATED INFORMATION – Crescent Share Consolidation

Leuven, Belgium – 5 January 2026 – 6:00 PM CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) Crescent (Euronext Brussel: OPTI) ) announced today that its Board of Directors, authorized by the General Meeting of May 31, 2025, will proceed with a consolidation of all existing shares. This consolidation will be carried out

REGULATED INFORMATION – Crescent Share Consolidation Read More »

Leuven, Belgium – 5 January 2026 – 6:00 PM CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) Crescent (Euronext Brussel: OPTI) ) announced today that its Board of Directors, authorized by the General Meeting of May 31, 2025, will proceed with a consolidation of all existing shares. This consolidation will be carried out

REGULATED INFORMATION – Disclosure on a transparency notification (Article 14(1) of the Law of 2 May 2007 on disclosure of major shareholdings)

Leuven, Belgium – 5 January 2026 – 6:00 PM CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) – CRESCENT NV, renamed to “OPTION” NV, (EURONEXT: OPTI), has received on 31 December 2025 a transparency notification from VAN ZELE HOLDING NV, indicating that the 35% participation threshold had been exceeded. The relevant details of

REGULATED INFORMATION – Disclosure on a transparency notification (Article 14(1) of the Law of 2 May 2007 on disclosure of major shareholdings) Read More »

Leuven, Belgium – 5 January 2026 – 6:00 PM CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) – CRESCENT NV, renamed to “OPTION” NV, (EURONEXT: OPTI), has received on 31 December 2025 a transparency notification from VAN ZELE HOLDING NV, indicating that the 35% participation threshold had been exceeded. The relevant details of

Visual Board of directors

Crescent Board of Directors

The articles of association stipulate that the Board of Directors is composed of at least three and not more than nine members, appointed by the general shareholders’ meeting for a period of not more than six years. The Board of Directors must include at least three independent directors. The Board of Directors is currently composed

Crescent Board of Directors Read More »

The articles of association stipulate that the Board of Directors is composed of at least three and not more than nine members, appointed by the general shareholders’ meeting for a period of not more than six years. The Board of Directors must include at least three independent directors. The Board of Directors is currently composed

REGULATED INFORMATION – Disclosure pursuant to Article 15 of the Act of 2 May 2007 (the Transparency Act) and announcement of the results of the Extraordinary General Meeting of 30 December 2025

Leuven, Belgium – 30 December 2025 – 6:00 PM CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) held an Extraordinary General Meeting on 30 December 2025. The shareholders approved all items on the agenda of the Extraordinary General Meeting. The Company’s capital was increased by EUR 415,929.17 on 30 December 2025 as a

REGULATED INFORMATION – Disclosure pursuant to Article 15 of the Act of 2 May 2007 (the Transparency Act) and announcement of the results of the Extraordinary General Meeting of 30 December 2025 Read More »

Leuven, Belgium – 30 December 2025 – 6:00 PM CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) held an Extraordinary General Meeting on 30 December 2025. The shareholders approved all items on the agenda of the Extraordinary General Meeting. The Company’s capital was increased by EUR 415,929.17 on 30 December 2025 as a

Visual meeting room

Extraordinary General Meeting 30 December 2025

DATE OF SHAREHOLDERS’ MEETING: 30 December 2025 Convocation Extraordinary General Meeting (including agenda) (NL) Convocation Extraordinary General Meeting (including agenda) (UK)   Related documents Volmachtformulier Stemformulier Bijzonder verslag van de Raad van Bestuur Toegestane Kapitaal CV Nick Vermeersch Bijz verslag toegestane kap Bijz verslag RvB art 7.180 Bijz verslag RvB 7-179_7 Crescent-NV verslag commissaris belangenconflict

Extraordinary General Meeting 30 December 2025 Read More »

DATE OF SHAREHOLDERS’ MEETING: 30 December 2025 Convocation Extraordinary General Meeting (including agenda) (NL) Convocation Extraordinary General Meeting (including agenda) (UK)   Related documents Volmachtformulier Stemformulier Bijzonder verslag van de Raad van Bestuur Toegestane Kapitaal CV Nick Vermeersch Bijz verslag toegestane kap Bijz verslag RvB art 7.180 Bijz verslag RvB 7-179_7 Crescent-NV verslag commissaris belangenconflict

Visual meeting room

Since the attendance quorum at the Extraordinary General Meeting of 8 December 2025 was not reached, the Board of Directors invites the Shareholders to participate in the Extraordinary General Meeting of CRESCENT NV, which will take place on 30 December 2025 at 9:00 a.m. at the Company’s registered office and which will decide on the

Read More »

Since the attendance quorum at the Extraordinary General Meeting of 8 December 2025 was not reached, the Board of Directors invites the Shareholders to participate in the Extraordinary General Meeting of CRESCENT NV, which will take place on 30 December 2025 at 9:00 a.m. at the Company’s registered office and which will decide on the

OCCASIONAL PRESS RELEASE – Crescent and Sol.One sign a three-year frame agreement

Leuven, Belgium – 18 November 2025 – 7:30 CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) Crescent NV (Euronext Brussels: OPTI) and Sol.One announce the signing of a three-year frame agreement covering engineering support and procurement services from Crescent for the production of up to 6000 next generation drones by Sol.One. This agreement

OCCASIONAL PRESS RELEASE – Crescent and Sol.One sign a three-year frame agreement Read More »

Leuven, Belgium – 18 November 2025 – 7:30 CET, Crescent NV, Geldenaaksebaan 329, 3001 Heverlee (Euronext Brussels: OPTI) Crescent NV (Euronext Brussels: OPTI) and Sol.One announce the signing of a three-year frame agreement covering engineering support and procurement services from Crescent for the production of up to 6000 next generation drones by Sol.One. This agreement

Visual meeting room

Extraordinary General Meeting 2025

DATE OF SHAREHOLDERS’ MEETING: 8 December 2025 Convocation Extraordinary General Meeting (including agenda) (NL) Convocation Extraordinary General Meeting (including agenda) (UK)   Related documents Volmachtformulier Stemformulier Bijzonder verslag van de Raad van Bestuur Toegestane Kapitaal CV Nick Vermeersch Bijz verslag toegestane kap Bijz verslag RvB art 7.180 Bijz verslag RvB 7-179_7 Crescent-NV verslag commissaris belangenconflict

Extraordinary General Meeting 2025 Read More »

DATE OF SHAREHOLDERS’ MEETING: 8 December 2025 Convocation Extraordinary General Meeting (including agenda) (NL) Convocation Extraordinary General Meeting (including agenda) (UK)   Related documents Volmachtformulier Stemformulier Bijzonder verslag van de Raad van Bestuur Toegestane Kapitaal CV Nick Vermeersch Bijz verslag toegestane kap Bijz verslag RvB art 7.180 Bijz verslag RvB 7-179_7 Crescent-NV verslag commissaris belangenconflict